The Lancet Diabetes & Endocrinology in conversation with

Sanjay Basu on affordable T2D medicine in LMICs

November 16, 2021 The Lancet Diabetes & Endocrinology
The Lancet Diabetes & Endocrinology in conversation with
Sanjay Basu on affordable T2D medicine in LMICs
Show Notes

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries.

Read the full article:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltext

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv